Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario

Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario

Immune checkpoint inhibitors (ICIs) and platinum-based chemotherapy (CT) are effective therapeutic agents for the palliative treatment of metastatic non-small-cell lung cancer (NSCLC); the aim of our study was to investigate the acute and chronic renal toxicities in this setting. We collected data o...

Full description

Bibliographic Details
Main Authors: Francesco Trevisani, Federico Di Marco, Matteo Floris, Antonello Pani, Roberto Minnei, Mario Scartozzi, Alessio Cirillo, Alain Gelibter, Andrea Botticelli, Erika Rijavec, Monica Cattaneo, Ornella Garrone, Michele Ghidini
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Vaccines
Subjects:
immune checkpoint inhibitors
immunotherapy
cisplatin
carboplatin
onconephrology
renal toxicity
Online Access:https://www.mdpi.com/2076-393X/10/5/679

Internet

https://www.mdpi.com/2076-393X/10/5/679

Similar Items